Abstract 6242: Inhibition of BIRC5/survivin by LQZ-7I inhibits neuroblastoma growth while hemizygosity of BIRC5 does not: implications for therapy of neuroblastoma

For full functionality of ScholarMagic it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

up vote 0 down vote

**Abstract 6242: Inhibition of BIRC5/survivin by LQZ-7I inhibits neuroblastoma growth while hemizygosity of BIRC5 does not: implications for therapy of neuroblastoma**

C Dorneburg, et al. (2023)
Cancer Research

up vote 0 down vote

There is no summary for this article.

Medical and Health Science

citation rate

Insert citation
	Comments
	Share
	Details
Shortlist	Citation

Abstract

Comments are visible to all users.

Your personal notes related to this publication. These notes are only visible to you, will save automatically, and will be here when you come back.

Authors:	C Dorneburg, C Galliger, V Rasche, A Lechel, TF Barth, KM Debatin, C Beltinger
Year published:	2023
DOI:	10.1158/1538-7445.am2023-6242
Full-text available:	Yes
Journal:	Cancer Research
Publisher:	American Association for Cancer Research (AACR)

Report an issue